Success Metrics

Clinical Success Rate
90.9%

Based on 10 completed trials

Completion Rate
91%(10/11)
Active Trials
6(29%)
Results Posted
30%(3 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_2
4
19%
Ph phase_3
1
5%
Ph not_applicable
13
62%

Phase Distribution

0

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution18 total trials
Phase 2Efficacy & side effects
4(22.2%)
Phase 3Large-scale testing
1(5.6%)
N/ANon-phased studies
13(72.2%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

6

trials recruiting

Total Trials

21

all time

Status Distribution
Active(7)
Completed(10)
Terminated(1)
Other(3)

Detailed Status

Completed10
Recruiting6
unknown3
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
21
Active
6
Success Rate
90.9%
Most Advanced
Phase 3

Trials by Phase

Phase 24 (22.2%)
Phase 31 (5.6%)
N/A13 (72.2%)

Trials by Status

recruiting629%
completed1048%
not_yet_recruiting15%
terminated15%
unknown314%

Recent Activity

Clinical Trials (21)

Showing 20 of 21 trialsScroll for more
NCT07494838Not Applicable

IMAGES: Identifying Metabolic Imaging Association With Genicular Artery Embolization Success

Not Yet Recruiting
NCT06095050Not Applicable

Embolization Treatment of Chronic Refractory Shoulder Tendinopathy

Recruiting
NCT03407963Not Applicable

Feasibility of Prostatic Arterial Embolization in Low-risk Patients With Unilateral Prostate Cancer Under Active Surveillance: Monocentric Pilot Study

Completed
NCT04006431

Prostate Embolization in Chronically Surveyed Patients: Effectiveness of Unilateral vs. Bilateral Embolization

Completed
NCT06466330Not Applicable

Efficacy of Microparticle Geniculate Artery Embolization in Total Knee Prosthesis Patients With Pain Resistant to Medical Treatment. A Prospective Randomized Controlled Trial

Recruiting
NCT00661622Phase 2

Halt Growth of Liver Tumors From Uveal Melanoma With Closure of Liver Artery Following Injection of GM-CSF

Completed
NCT03853434Not Applicable

Efficacy of Angiographic Embolization vs Non-embolization of Moderate/Poor Vascularized Vertebral Metastases on Intraoperative Bleeding During Surgery Decompression and Vertebral Stabilization.

Recruiting
NCT05428735Not Applicable

The DRAGON 2 Trial

Recruiting
NCT01678664Phase 2

Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine Tumors

Completed
NCT02098252Not Applicable

Treatment of Brain AVMs (TOBAS) Study

Recruiting
NCT05714124

Liver Embolization Approaches for Tumor Management

Recruiting
NCT03884049Not Applicable

Neovascularization Embolisation for Knee Osteoarthritis.(NEO)

Completed
NCT00003907Phase 2

Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver

Completed
NCT03808766Not Applicable

A Study on the Angioarchitecture of Hepatocellular Carcinoma

Terminated
NCT05550649Not Applicable

Safety and Efficacy of Prophylactic Arterial Embolization in the Treatment of Angiography-negative Acute Upper Gastrointestinal Bleeding

Unknown
NCT03402282Not Applicable

Upper Rectal Artery Embolization in the Treatment of Hemorrhoidal Disease

Completed
NCT00839722Phase 2

Fertility After Uterine Artery Embolisation for the Treatment of Leiomyomas

Completed
NCT01229839Phase 3

Chemoembolization With or Without Mixing the Chemotherapy With Lipiodol for Unresectable HCC

Completed
NCT02021396Not Applicable

Benefit of Prophylactic Embolization of the Splenic Salvage

Completed
NCT03231202Not Applicable

Splenic Injury Embolization - the Question About NOM (SInE Qua NOM)

Unknown

Drug Details

Intervention Type
DEVICE
Total Trials
21